Login / Signup

Device-related complications in the subcutaneous and transvenous ICD: a secondary analysis of the PRAETORIAN trial.

Reinoud E KnopsShari PepplinkhuizenPeter Paul H M DelnoyLucas V A BoersmaJuergen KuschykMikhael F El-ChamiHendrik BonnemeierElijah R BehrTom F BrouwerStefan KaabSuneet MittalAnne Floor B E QuastWilleke van der StuijtLonneke SmedingJolien A de VeldJan G P TijssenNick R BijsterveldSergio RichterMarc A BrouwerJoris R de GrootKirsten M KooimanPier D LambiasePetr NeuzilKevin VernooyMarco AlingsTimothy R BettsFrank A L E BrackeMartin C BurkeJonas S S G de JongDavid J WrightWard P J JansenZachary I WhinnettPeter NordbeckMichael KnautBerit T PhilbertJurren M van OpstalAlexandru B ChicosCornelis P AllaartAlida E Borger van der BurgJose M DizonMarc A MillerDmitry NemirovskyRalf SurberGaurav A UpadhyayRaul WeissAnouk de WegerArthur A M WildeLouise R A Olde Nordkamp
Published in: European heart journal (2022)
This secondary analysis shows that, lead-related complications and systemic infections are more prevalent in the TV-ICD group compared to the S-ICD group. In addition, complications in the TV-ICD group were more severe as they required significantly more invasive interventions. This data contributes to shared decision making in clinical practice.
Keyphrases
  • risk factors
  • clinical practice
  • clinical trial
  • study protocol
  • physical activity
  • electronic health record
  • randomized controlled trial
  • drug induced
  • phase iii
  • deep learning
  • artificial intelligence